1. Search Result
Search Result
Results for "

ionizable amino lipid

" in MedChemExpress (MCE) Product Catalog:

26

Inhibitors & Agonists

11

Biochemical Assay Reagents

25

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-145799
    5A2-SC8
    1 Publications Verification

    Liposome Cancer
    5A2-SC8 is an ionizable amino lipid in lipid nanoparticles (LNPs) that shows high delivery potential and low in vivo toxicity, enabling efficient delivery of small RNAs such as siRNA and miRNA into tumor cells. 5A2-SC8 LNPs can confer a unique delivery fate of RNA within the liver, thereby changing the therapeutic outcomes in cancer models .
    5A2-SC8
  • HY-153378

    Liposome Others
    Lipid 15 is an ionizable amino lipid used for the generation of Lipid nanoparticles (LNPs).
    Lipid 15
  • HY-148648

    Liposome Others
    Lipid 29 is an ionizable amino lipid. Lipid 29 can be used to form lipid nanoparticles .
    Lipid 29
  • HY-150115
    Lipid 10
    1 Publications Verification

    Liposome Others
    Lipid 10 is an ionizable amino lipid used for the generation of Lipid nanoparticles (LNPs).
    Lipid 10
  • HY-134782

    Liposome Others
    OF-Deg-Lin is an ionizable amino lipid used for the generation of Lipid nanoparticles (LNPs).
    OF-Deg-Lin
  • HY-153377

    Liposome SARS-CoV Bacterial Infection Inflammation/Immunology
    Lipid 14 is an ionizable amino lipid. Lipid 14 delivers mRNA into target cells, significantly enhancing the in vivo expression efficiency and immunogenicity of mRNA. Lipid 14 can be used to synthesize lipid nanoparticles (LNPs). Lipid 14 can be used for studies of SARS-CoV-2 and Yersinia pestis .
    Lipid 14
  • HY-150118

    Liposome Others
    Lipid 8 is an ionizable amino lipid that can be used to synthesize lipid nanoparticles (LNPs). Lipid 8 is applicable to research in drug delivery .
    Lipid 8
  • HY-145799A
    5A2-SC8 TFA
    1 Publications Verification

    Liposome Cancer
    5A2-SC8 TFA is an ionizable amino lipid in lipid nanoparticles (LNPs) that shows high delivery potential and low in vivo toxicity, enabling efficient delivery of small RNAs such as siRNA and miRNA into tumor cells. 5A2-SC8 TFA LNPs can confer a unique delivery fate of RNA within the liver, thereby changing the therapeutic outcomes in cancer models .
    5A2-SC8 TFA
  • HY-150116

    Liposome Others
    Lipid 1 is an ionizable amino lipid used for the generation of Lipid nanoparticles (LNPs).
    Lipid 1
  • HY-153376

    Liposome Others
    LNP Lipid-6 (Compound Lipid 5) is an ionizable lipid (amino lipid). LNP Lipid-6 can be used to prepare lipid nanoparticles (LNP) .
    LNP Lipid-6
  • HY-153375

    Liposome Others
    LNP Lipid-5 (Compound Lipid 2) is an ionizable lipid (amino lipid). LNP Lipid-5 can be used to prepare lipid nanoparticles (LNP) .
    LNP Lipid-5
  • HY-150117

    Liposome Others
    Lipid 6 is an ionizable amino lipid. Lipid 6 can be used to synthesize lipid nanoparticles. Lipid 6 can be used in RNA delivery research .
    Lipid 6
  • HY-159860

    A10-Lin

    Liposome Others
    IR-117-17 is an ionizable cationic amino lipid, targeting conducting airways of the lung. IR-117-17 could be degraded via esterase cleavage and thus be unlikely to accumulate upon repeated dosing . It can be used in research related to diseases that manifest outside alveolar spaces.
    IR-117-17
  • HY-172018

    Liposome Cancer
    CP-LC-0729 is an ionizable cationic amino lipid efficient delivery of different kinds of RNA (mRNA, cRNA and saRNA) .
    CP-LC-0729
  • HY-158861

    G1-nPr-C14E

    Liposome Others
    C3-K2-E14 is a multi-ionizable amino-lipid featuring a central tertiary amine with two identical branches and an n-propyl group. Each branch features a propanamide linking to a branched amine, each with two C14 arms and a hydroxyl. Ionizable lipids such as this may be applied in the development of lipid nanoparticles for drug discovery.
    C3-K2-E14
  • HY-159735

    Liposome Others
    Lipid 23 is an ionizable cationic amino lipid that can be used to generate lipid nanoparticles (LNP). Lipid 23 can be used for mRNA delivery .
    Lipid 23
  • HY-159725

    Liposome Others
    BAmP-O16B is an ionizable cationic amino lipid that can be used to generate lipid nanoparticles (LNPs) .
    BAmP-O16B
  • HY-171113

    Liposome Cancer
    CP-LC-1143 is an ionizable cationic amino lipid efficient delivery of different kinds of RNA (mRNA, cRNA and saRNA).
    CP-LC-1074
  • HY-172014

    Liposome Cancer
    CP-LC-0743 is an ionizable cationic amino lipid efficient delivery of different kinds of RNA (mRNA, cRNA and saRNA) .
    CP-LC-0743
  • HY-172016

    Liposome Cancer
    CP-LC-0867 is an ionizable cationic amino lipid efficient delivery of different kinds of RNA (mRNA, cRNA and saRNA) .
    CP-LC-0867
  • HY-172015

    Liposome Cancer
    CP-LC-1143 is an ionizable cationic amino lipid efficient delivery of different kinds of RNA (mRNA, cRNA and saRNA) .
    CP-LC-1143
  • HY-172925

    Liposome Others
    CP-LC-1447 is an ionizable cationic amino lipid derived from homocysteine.
    CP-LC-1447
  • HY-172017

    Liposome Cancer
    CP-LC-1254 is an ionizable cationic amino lipid efficient delivery of different kinds of RNA (mRNA, cRNA and saRNA) .
    CP-LC-1254
  • HY-W1130407

    Liposome Others
    CP-LC-1073 is a specific ionizable cationic amino lipid derived from the amino acid homocysteine. CP-LC-1073 can used in lipid nanoparticle (LNP) formulations for efficient in vivo delivery and expression of RNA (mRNA, cRNA, saRNA).
    CP-LC-1073
  • HY-176027

    Liposome Others
    CP-LC-1422 is a homocysteine-derived ionizable amino lipid with high RNA delivery capability and can mediate high-level protein expression in vivo. CP-LC-1422 exhibits significant spleen targeting via intravenous injection in a lipid nanoparticle (LNP) formulation with no significant toxicity observed .
    CP-LC-1422
  • HY-172926

    Others Others
    CP-LC-1428 is an ionizable cationic amino lipid derived from homocysteine. CP-LC-1428 can be used for efficient delivery of various RNAs and achieve high protein expression. CP-LC-1428 can specifically target the spleen and has no obvious toxicity .
    CP-LC-1428

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: